During your consultation, well help review your options and discuss self-pay solutions if coverage isnt available
A pooled analysis of the STEP 1 through STEP 3 trials, published in Diabetes, Obesity and Metabolism in 2022, examined once-weekly semaglutide 2.4 mg in 2,117 participants against 1,262 on placebo
During the Digestive Disease Week Conference in 2024 , scientists claimed that GLP-1 and its side effects could eventually lead to gastroparesis, which is defined as the slowing down of your stomachs digestion
10.2174/1381612826666200212113903 Curr Pharm Des
Shara Wesley , assistant vice president, Community Health and Wellstar Center for Health Equity (WCHE)